Investors About us Products Pharmaceuticals INVI AION News Contact us Search AKER BIOMARINE ASA Stock exchange releases Aker BioMarine ASA presents Q3 2021 Results 29.10.21 Aker BioMarine ASA is pleased to announce that Carl Christian Bachke has been appointed SVP Investor Relations effective from 1 October 2021. 02.09.21 Aker BioMarine ASA presents Q2 2021 Results 14.07.21 Latest company disclosures Investor Contact CARL CHR. BACHKE SVP Investor Relations, Aker BioMarine ASA +47 909 808 48 carl.bachke@akerbiomarine.com ANNUAL REPORT 2020 IMPROVING HUMAN AND PLANETARY HEALTH Aker BioMarine is a biotech innovator and Antarctic krill-harvesting company, dedicated to improving human and planetary health. Aker BioMarine’s fully transparent value chain stretches from sustainable krill harvesting in pristine Antarctic waters through its Montevideo logistics hub, Houston production plant, and to customers around the world. Read and download OUR PRODUCTS For human health For aquaculture For pets SITE Products About us Careers Blog News Contact us FIND US CONTACT US Aker BioMarine ASA, Oksenøyveien 10, P.O. Box 496, NO-1327 Lysaker, Norway © AKER BIOMARINE. ALL RIGHTS RESERVED. TERMS AND CONDITIONS